Seattle, Sept. 29, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global cell culture market is estimated to be valued at US$ 19,198.0 million in 2022 and is expected to exhibit a CAGR of 7.2 % during the forecast period (2022-2030).
Key Trends and Analysis of the Global Cell Culture Market:
Regenerative therapy research has attained tremendous growth in recent years due to the large amounts of investments funneled into this domain. As cell culture techniques constitute an essential step in such research applications, market is expected to witness significant growth in the near future. Key players involved in market are undertaking initiatives to extend their product portfolios and strengthen their market position. For instance, in January 2022, Cytiva, a company involved in the research and development of life-saving vaccines, biologic drugs, and novel cell and gene therapies, collaborated with Nucleus Biologics, a company involved in precision cell culture providing cell culture media and cell culture, to develop custom culture media for cell and gene therapies.
Advancements in 3D culture technologies and their increasing adoption for biopharmaceutical production, drug discovery, and tissue engineering applications is also expected to boost the market growth. For instance, in March 2022, CELLINK, a subsidiary of BICO, a bioconvergence startup that designs and supplies technologies and services to enhance biology research, launched its BIO CELLX bio-dispensing platform for the automation of 3D cell-based assays for drug discovery and cancer research. Such product launches are likely to broaden the growth prospects for the segment.
Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/116
Key Market Takeaways:
Global cell culture market is expected to exhibit a CAGR of 7.2 % during the forecast period due to increase in collaborations by key market players. For instance, on May 13, 2022, Kerry Group, a public food company, announced collaboration with National Institute for Bioprocessing Research and Training (NIBRT) and ValitaCell, a biotechnology company, to validate the role of protein hydrolysates in cell culture media during the commercial manufacture of biotherapeutics.
Among end user, pharmaceutical and biotechnology companies segment held a dominant position in the global cell culture market, owing to increasing investments in research and development from major manufacturers, and increasing product launches. For instance, in May 2019, Thermo Fisher Scientific Inc. launched GIBCO CTS LV-MAX Lentiviral Production System. The new system is designed to produce high titer lentiviral vectors. The launch of the system is expected to enhance Thermo Fisher Scientific Inc. market position in cell and gene therapy portfolio.
Competitive Landscape:
Key players operating in the global cell culture market include Corning Incorporated, Merck KGaA, Sartorius AG, BioSpherix, Ltd., Cell Culture Company, LLC, Thermo Fisher Scientific Inc., VWR International LLC, and Lonza
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/116
Market Segmentation:
- Global Cell Culture Market, By Product Type:
- Instrument
- Culture Systems
- Vaccines
- Bags
- Plates
- T-flasks
- Culture Dishes
- Roller Bottles
- Bioreactors
- Incubators
- Pipetting Instruments
- Roller Bottle Equipment
- Biosafety Cabinets
- Cryostorage Equipment
- Others
- Culture Systems
- Consumables
- Media
- Chemically Defined
- Classical
- LB
- Protein-free
- Serum-free
- Specialty
- Sera
- Fetal Bovine
- Others
- Reagents
- Albumin
- Amino Acids
- Attachment Factors
- Growth Factors
- Protease Inhibitors
- Thrombin
- Others
- Media
- Instrument
- Global Cell Culture Market, By Application:
- Vaccine Production
- Gene Therapy
- Cancer Research
- Tissue Culture
- Drug Development
- Others
- Global Cell Culture Market, By End User:
- Academic & Research Institutions
- Pharmaceutical and Biotechnology Companies
- Global Cell Culture Market, By Region:
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- By Region/Country
- North America
Related Market Intelligence Reports:
3D Cell Culture Market, by Technology (Extracellular Matrices or Scaffolds, Bioreactors, Gels, Scaffold-free Platforms, and Microchips), by Application (Research, Drug Discovery, Tissue Engineering, Clinical Applications, and Stem Cell Biology), by End User (Research Labs & Institutes, Biopharmaceutical Industry, Hospitals And Diagnostic Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027
Cell Culture Media for Vaccine Market - by Media Type (Bovine Derived, Porcine Derived, and Animal Free/Serum Free Cell Culture), by Application (Human Vaccine and Animal Vaccine), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
Cell Culture Monitoring Biosensors Market, by Product Type (Electrochemical Biosensors, Thermometric Biosensors, Fiber Optic Biosensors, Piezoelectric Biosensors, and Others), By End User (Pharmaceutical Industry, Biotechnology Organizations, and Research Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
